Stat, The Boston Globes’s national health and science website, tosses us a story

Boston Health News

ssWe don’t know if the copy is going to be in the paper or just online, but today, Stat makes its debut — in both formats. The site promises “Reporting from the frontiers of health and medicine We take you inside the science labs and hospitals, biotech boardrooms and political backrooms. We dissect crucial discoveries. We examine controversies and puncture hype. We hold individuals and institutions accountable. We introduce you to the power brokers and personalities who are driving a revolution in human health.

Today’s story –how social media is gumming up clinical trials and riling  up pharma investors. It begins with a story of a woman who posts about being in a clinical trial.

The stock of a Cambridge-based biotech company would rise and fall with her updates. Investors would scrutinize Stracham’s words and pore over individual frames in her videos. Stracham herself would be subjected to…

View original post 293 more words

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s